■ Novel Coronavirus Information Center
Elsevier´s free health and medical research on the novel coronavirus (SARS-CoV-2) and COVID-19 – updated april 2020
https://www.elsevier.com/connect/coronavirus-information-center
■ COVID-19: What has been learned and to be learned about the novel coronavirus disease
Ye Yi, Philip N.P. Lagniton, Sen Ye, Enqin Li, Ren-He Xu
Int J Biol Sci. 2020; 16(10): 1753–1766
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098028/
■ What can early Canadian experience screening for COVID-19 teach us avout how to prepare for a pandemic?
Molly Lin, Alina Beliavsky, Kevin Katz, et al
CMAJ. 2020 Mar 23; 192(12): E314–E318
https://www.cmaj.ca/content/192/12/E314
Estimates of the severity of coronavirus disease 2019: a model-based analysis
R Verity, L C Okell, I Dorigatti et al
The Lancet Infectious Diseases march 30, 2020
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30243-7/fulltext
■ COVI-19: a remote assessment in primary care
T Greenhalgh, G C H Koh, J Car
BMJ 2020, vol 368: m1182
https://www.bmj.com/content/368/bmj.m1182
■ Coronavirus disease 2019 (covid-19): a guide for UK GPs
BMJ 2020, vol 368: m800
Na updated module from BMJ Best Practice
https://bestpractice.bmj.com/topics/en-gb/3000168#important-update
■ A review of coronavirus disease-2019 (COVID-19)
Tanu Singhal
Indian J Pediatr. 2020; 87(4): 281–286.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090728/
■ First case of 2019 novel coronavirus in the United States
Michelle L. Holshue, Chas DeBolt, Scott Lindquist, et al
N Engl J Med. 2020 Mar 5; 382(10): 929–936
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092802/
■ Research and development on therapeutic agentes and vacines for COVID-19 and related human coronavirus diseases
Cynthia Liu, Qiongqiong Zhou, Yingzhu Li, et al
ACS Cent Sci. 2020 Mar 25; 6(3): 315–331
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094090/
■ The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status
Yan-Rong Guo, Qing-Dong Cao, Zhong-Si Hong, Yuan-Yang
Mil Med Res. 2020; 7: 11
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068984/
■ COVID-19 and the cardiovascular system
Ying-Ying Zheng, Yi-Tong Ma, Jin-Ying Zhang, Xiang Xie
Nat Rev Cardiol. 2020 Mar 5 : 1–2
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095524/
■ The cardiovascular burden of coronavirus disease 2019 (COVID-19)
Weiyi Tan, Jamil Aboulhosn
Int J Cardiol. 2020 Mar 2
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102656/
■ Surviving sepsis Campaign: guidelines on the management of critically ill adullts with Coronavirus Disease 2019 (COVID-19)
Waleed Alhazzani, Morten Hylander Møller, Yaseen M. Arabi, et al
Intensive Care Med. 2020 Mar 28 : 1–34
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101866/
■ Dr Paulo Fernando Leite
Cardiologia/Prevenção Cardiovascular
Estratificação de Risco Cardiovascular
Consultório: Rua Padre Rolim 815/sala 601 – Belo Horizonte/MG/Brasil
Tel: 33245518
CRMMG: 7026
Email: pfleite1873@gmail.com
Data: abril 2020